Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim W Harrison

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Pediatrics|August 27, 2018
Quintupling inhaled fluticasone at first sign of exacerbationTim W Harrison
Lancet (London, England)|April 4, 2003
Low-dose budesonide for asthmaAnne E Tattersfield, Tim W Harrison
The European Respiratory Journal|April 6, 2019
Is it time to move away from short-acting beta-agonists in asthma management?Matthew J Martin, Tim W Harrison
Respiratory Medicine|July 18, 2015
Causes of chronic productive cough: An approach to managementMatthew J Martin, Tim W Harrison
Expert Review of Respiratory Medicine|November 13, 2018
Can a temporary increase in corticosteroid dosage reduce asthma exacerbations?Lissa G Sutherland, Tim W Harrison
Thorax|August 26, 2020
Towards a personalised treatment approach for asthma attacksMatthew J Martin, Richard Beasley, Tim W Harrison
International Journal of Chronic Obstructive Pulmonary Disease|November 2, 2017
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPDChrister Janson, Georgios Stratelis, Anna Miller-Larsson, et al.
American Journal of Respiratory and Critical Care Medicine|July 11, 2009
Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trialJanet Oborne, Kevin Mortimer, Richard B Hubbard, et al.
Respiratory Research|November 3, 2009
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trialChris Dalby, Tomasz Polanowski, Thomas Larsson, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Inhaled corticosteroids and hip fracture: a population-based case-control studyRichard B Hubbard, Chris J P Smith, Liam Smeeth, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|August 27, 2018
Quintupling inhaled fluticasone at first sign of exacerbationTim W Harrison
Lancet (London, England)|April 4, 2003
Low-dose budesonide for asthmaAnne E Tattersfield, Tim W Harrison
The European Respiratory Journal|April 6, 2019
Is it time to move away from short-acting beta-agonists in asthma management?Matthew J Martin, Tim W Harrison
Respiratory Medicine|July 18, 2015
Causes of chronic productive cough: An approach to managementMatthew J Martin, Tim W Harrison
Expert Review of Respiratory Medicine|November 13, 2018
Can a temporary increase in corticosteroid dosage reduce asthma exacerbations?Lissa G Sutherland, Tim W Harrison
Thorax|August 26, 2020
Towards a personalised treatment approach for asthma attacksMatthew J Martin, Richard Beasley, Tim W Harrison
International Journal of Chronic Obstructive Pulmonary Disease|November 2, 2017
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPDChrister Janson, Georgios Stratelis, Anna Miller-Larsson, et al.
American Journal of Respiratory and Critical Care Medicine|July 11, 2009
Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trialJanet Oborne, Kevin Mortimer, Richard B Hubbard, et al.
Respiratory Research|November 3, 2009
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trialChris Dalby, Tomasz Polanowski, Thomas Larsson, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Inhaled corticosteroids and hip fracture: a population-based case-control studyRichard B Hubbard, Chris J P Smith, Liam Smeeth, et al.
Pageof 3